{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:42:02Z","timestamp":1790430122290,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["16H06402A01"],"award-info":[{"award-number":["16H06402A01"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["17H042470001"],"award-info":[{"award-number":["17H042470001"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16768966"],"award-info":[{"award-number":["16768966"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant-in-Aid for Research and Development Grants for Dementia","award":["16768966"],"award-info":[{"award-number":["16768966"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00415-019-09400-2","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:20:22Z","timestamp":1559067622000},"page":"2186-2196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"266","author":[{"given":"Tatsuhiro","family":"Terada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Yokokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Bunai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuji","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Suhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuomi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"9400_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia J Alzheimer\u2019s Assoc 7:270\u2013279","journal-title":"Alzheimer\u2019s Dementia J Alzheimer\u2019s Assoc"},{"key":"9400_CR2","first-page":"1113","volume":"3","author":"R Annicchiarico","year":"2007","unstructured":"Annicchiarico R, Federici A, Pettenati C, Caltagirone C (2007) Rivastigmine in Alzheimer\u2019s disease: cognitive function and quality of life. Ther Clin Risk Manag 3:1113\u20131123","journal-title":"Ther Clin Risk Manag"},{"key":"9400_CR3","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, Kugler S, Ikezu T (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18:1584\u20131593","journal-title":"Nat Neurosci"},{"key":"9400_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"9400_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jalz.2012.01.011","volume":"8","author":"H Braak","year":"2012","unstructured":"Braak H, Del Tredici K (2012) Alzheimer\u2019s disease: pathogenesis and prevention. Alzheimer\u2019s Dementia J Alzheimer\u2019s Assoc 8:227\u2013233","journal-title":"Alzheimer\u2019s Dementia J Alzheimer\u2019s Assoc"},{"key":"9400_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001) In-vivo measurement of activated microglia in dementia. Lancet 358:461\u2013467","journal-title":"Lancet"},{"key":"9400_CR7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/NEN.0000000000000251","volume":"74","author":"JO Carlson","year":"2015","unstructured":"Carlson JO, Gatz M, Pedersen NL, Graff C, Nennesmo I, Lindstrom AK, Gerritsen L (2015) Antemortem prediction of braak stage. J Neuropathol Exp Neurol 74:1061\u20131070","journal-title":"J Neuropathol Exp Neurol"},{"key":"9400_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/ijms18050993","volume":"18","author":"C Cerami","year":"2017","unstructured":"Cerami C, Iaccarino L, Perani D (2017) Molecular imaging of neuroinflammation in neurodegenerative dementias: the role of in vivo PET imaging. Int J Mol Sci 18:993","journal-title":"Int J Mol Sci"},{"key":"9400_CR9","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00259-018-4012-5","volume":"45","author":"K Chiotis","year":"2018","unstructured":"Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A (2018) Dual tracer tau PET imaging reveals different molecular targets for (11)C-THK5351 and (11)C-PBB3 in the Alzheimer brain. Eur J Nucl Med Mol Imag 45:1605\u20131617","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"9400_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11307-009-0211-6","volume":"11","author":"J Doorduin","year":"2009","unstructured":"Doorduin J, Klein HC, Dierckx RA, James M, Kassiou M, de Vries EF (2009) [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis. Mol Imag Biol 11:386\u2013398","journal-title":"Mol Imag Biol"},{"key":"9400_CR11","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3174\/ajnr.A3355","volume":"34","author":"R Guggenberger","year":"2013","unstructured":"Guggenberger R, Fischer DR, Metzler P, Andreisek G, Nanz D, Jacobsen C, Schmid DT (2013) Bisphosphonate-induced osteonecrosis of the jaw: comparison of disease extent on contrast-enhanced MR imaging, [18F] fluoride PET\/CT, and conebeam CT imaging. AJNR Am J Neuroradiol 34:1242\u20131247","journal-title":"AJNR Am J Neuroradiol"},{"key":"9400_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"9400_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0006-8993(95)01407-1","volume":"712","author":"WA Jefferies","year":"1996","unstructured":"Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, McGeer PL (1996) Reactive microglia specifically associated with amyloid plaques in Alzheimer\u2019s disease brain tissue express melanotransferrin. Brain Res 712:122\u2013126","journal-title":"Brain Res"},{"key":"9400_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13550-016-0182-y","volume":"6","author":"Y Kimura","year":"2016","unstructured":"Kimura Y, Endo H, Ichise M, Shimada H, Seki C, Ikoma Y, Shinotoh H, Yamada M, Higuchi M, Zhang MR, Suhara T (2016) A new method to quantify tau pathologies with (11)C-PBB3 PET using reference tissue voxels extracted from brain cortical gray matter. EJNMMI Res 6:24","journal-title":"EJNMMI Res"},{"key":"9400_CR15","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2967\/jnumed.115.160127","volume":"56","author":"Y Kimura","year":"2015","unstructured":"Kimura Y, Ichise M, Ito H, Shimada H, Ikoma Y, Seki C, Takano H, Kitamura S, Shinotoh H, Kawamura K, Zhang MR, Sahara N, Suhara T, Higuchi M (2015) PET quantification of tau pathology in human brain with 11C-PBB3. J Nucl Med 56:1359\u20131365","journal-title":"J Nucl Med"},{"key":"9400_CR16","first-page":"437483","volume":"2014","author":"Y Li","year":"2014","unstructured":"Li Y, Tan MS, Jiang T, Tan L (2014) Microglia in Alzheimer\u2019s disease. Biomed Res Int 2014:437483","journal-title":"Biomed Res Int"},{"key":"9400_CR17","volume-title":"Atlas of the human brain","author":"Mai JrK","year":"1997","unstructured":"JrK Mai, Assheuer J, Paxinos G (1997) Atlas of the human brain. Academic Press, San Diego"},{"key":"9400_CR18","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON, Jiang S, Cardona A, Ransohoff RM, Lamb BT, Bhaskar K (2015) Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 138:1738\u20131755","journal-title":"Brain"},{"key":"9400_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","volume":"79","author":"M Maruyama","year":"2013","unstructured":"Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M, Masamoto K, Takano H, Sahara N, Iwata N, Okamura N, Furumoto S, Kudo Y, Chang Q, Saido TC, Takashima A, Lewis J, Jang MK, Aoki I, Ito H, Higuchi M (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79:1094\u20131108","journal-title":"Neuron"},{"key":"9400_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia J Alzheimer\u2019s Assoc 7:263\u2013269","journal-title":"Alzheimer\u2019s Dementia J Alzheimer\u2019s Assoc"},{"key":"9400_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, Rhodes C, Pulford DJ, Bennacef I, Parker CA, StJean PL, Cardon LR, Mooser VE, Matthews PM, Rabiner EA, Rubio JP (2012) An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 32:1\u20135","journal-title":"J Cereb Blood Flow Metab"},{"key":"9400_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","volume":"27","author":"V Papadopoulos","year":"2006","unstructured":"Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M (2006) Translocator protein (18\u00a0kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402\u2013409","journal-title":"Trends Pharmacol Sci"},{"key":"9400_CR23","first-page":"781","volume":"140","author":"L Passamonti","year":"2017","unstructured":"Passamonti L, Vazquez Rodriguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O\u2019Brien JT, Rowe JB (2017) 18F-AV-1451 positron emission tomography in Alzheimer\u2019s disease and progressive supranuclear palsy. Brain 140:781\u2013791","journal-title":"Brain"},{"key":"9400_CR24","first-page":"748","volume":"140","author":"MJ Pontecorvo","year":"2017","unstructured":"Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA (2017) Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain 140:748\u2013763","journal-title":"Brain"},{"key":"9400_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","volume":"12","author":"L Saint-Aubert","year":"2017","unstructured":"Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A (2017) Tau PET imaging: present and future directions. Mol Neurodegener 12:19","journal-title":"Mol Neurodegener"},{"key":"9400_CR26","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT (2017) Microglia in Alzheimer\u2019s disease. J Clin Invest 127:3240\u20133249","journal-title":"J Clin Invest"},{"key":"9400_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ (2016) PET imaging of Tau deposition in the aging human brain. Neuron 89:971\u2013982","journal-title":"Neuron"},{"key":"9400_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neurobiolaging.2003.09.009","volume":"25","author":"B Schonheit","year":"2004","unstructured":"Schonheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25:697\u2013711","journal-title":"Neurobiol Aging"},{"key":"9400_CR29","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9400_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.dadm.2016.12.009","volume":"6","author":"H Shimada","year":"2017","unstructured":"Shimada H, Kitamura S, Shinotoh H, Endo H, Niwa F, Hirano S, Kimura Y, Zhang MR, Kuwabara S, Suhara T, Higuchi M (2017) Association between Abeta and tau accumulations and their influence on clinical features in aging and Alzheimer\u2019s disease spectrum brains: a [11C]PBB3-PET study. Alzheimers Dement (Amst) 6:11\u201320","journal-title":"Alzheimers Dement (Amst)"},{"key":"9400_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, West BL, Green KN (2016) Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology. Brain 139:1265\u20131281","journal-title":"Brain"},{"key":"9400_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3200\/JOER.98.1.5-13","volume":"98","author":"FKCH Stage","year":"2004","unstructured":"Stage FKCH, Nora A (2004) Path analysis: an introduction and analysis of a decade of research. J Educ Res 98:5\u201313","journal-title":"J Educ Res"},{"key":"9400_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12149-016-1099-2","volume":"30","author":"T Terada","year":"2016","unstructured":"Terada T, Yokokura M, Yoshikawa E, Futatsubashi M, Kono S, Konishi T, Miyajima H, Hashizume T, Ouchi Y (2016) Extrastriatal spreading of microglial activation in Parkinson\u2019s disease: a positron emission tomography study. Ann Nucl Med 30:579\u2013587","journal-title":"Ann Nucl Med"},{"key":"9400_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922\u2013935","journal-title":"J Am Geriatr Soc"},{"key":"9400_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1749-6632.2000.tb05561.x","volume":"924","author":"JQ Trojanowski","year":"2000","unstructured":"Trojanowski JQ, Lee VM (2000) \u201cFatal attractions\u201d of proteins. A comprehensive hypothetical mechanism underlying Alzheimer\u2019s disease and other neurodegenerative disorders. Ann N Y Acad Sci 924:62\u201367","journal-title":"Ann N Y Acad Sci"},{"key":"9400_CR36","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/ijms18040802","volume":"18","author":"C Tronel","year":"2017","unstructured":"Tronel C, Largeau B, Santiago Ribeiro MJ, Guilloteau D, Dupont AC, Arlicot N (2017) Molecular targets for PET imaging of activated microglia: the current situation and future expectations. Int J Mol Sci 18:802","journal-title":"Int J Mol Sci"},{"key":"9400_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00259-010-1612-0","volume":"38","author":"M Yokokura","year":"2011","unstructured":"Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y (2011) In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer\u2019s disease. Eur J Nuclear Med Mol Imaging 38:343\u2013351","journal-title":"Eur J Nuclear Med Mol Imaging"},{"key":"9400_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0271678X16646788","volume":"37","author":"M Yokokura","year":"2017","unstructured":"Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, Yoshikawa E, Futatsubashi M, Suzuki K, Mori N, Ouchi Y (2017) Depiction of microglial activation in aging and dementia: positron emission tomography with [11C]DPA713 versus [11C](R)PK11195. J Cereb Blood Flow Metab 37:877\u2013889","journal-title":"J Cereb Blood Flow Metab"},{"key":"9400_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/NDT.S75546","volume":"11","author":"F Zhang","year":"2015","unstructured":"Zhang F, Jiang L (2015) Neuroinflammation in Alzheimer\u2019s disease. Neuropsychiatr Dis Treat 11:243\u2013256","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09400-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09400-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09400-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T23:44:19Z","timestamp":1608075859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09400-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["9400"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09400-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"4 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors TT, MY, TO, TB, EY, IA and YO declare no competing interests. HS, TS and MH hold patent on compounds related to the present report (JP 5422782\/EP 12 884 742.3), and the National Institutes for Quantum and Radiological Science and Technology made a license agreement with APRINOIA Therapeutics Inc. regarding this patent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}